Cell Cycle
Volume 20, 2021 - Issue 7
Open access
2,070
Views
0
CrossRef citations to date
0
Altmetric
Research Paper
Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters
Camilla Bjørnbak Holsta Department of Medicine, Herlev and Gentofte Hospital, Herlev, Denmark;b Department of Oncology, Herlev and Gentofte Hospital, Herlev, Denmark;c Brain Tumor Biology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark;d Department of Radiation Biology, Department of Oncology, Rigshospitalet, Copenhagen, Denmark;g Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkCorrespondence[email protected]
View further author information
, View further author information
Henriette Pedersenc Brain Tumor Biology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, DenmarkView further author information
, Elisabeth Anne Adanma Obarac Brain Tumor Biology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, DenmarkView further author information
, Kristoffer Vitting-Seerupc Brain Tumor Biology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, Denmark
https://orcid.org/0000-0002-6450-0608View further author information
Kamilla Ellermann Jensenc Brain Tumor Biology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, DenmarkView further author information
, Jane Skjøth-Rasmussene Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark
https://orcid.org/0000-0001-8689-9704View further author information
Eva Løbner Lundf Department of Pathology, Rigshospitalet, Copenhagen, DenmarkView further author information
, Hans Skovgaard Poulsend Department of Radiation Biology, Department of Oncology, Rigshospitalet, Copenhagen, DenmarkView further author information
, Julia Sidenius Johanseng Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;a Department of Medicine, Herlev and Gentofte Hospital, Herlev, Denmark;b Department of Oncology, Herlev and Gentofte Hospital, Herlev, DenmarkView further author information
& Petra Hamerlikc Brain Tumor Biology, Danish Cancer Society Research Center, Danish Cancer Society, Copenhagen, DenmarkView further author information
show all
Pages 702-715
|
Received 24 Jun 2020, Accepted 05 Mar 2021, Published online: 28 Mar 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.